Our data demonstrate that AMPK activation and changes in whole body insulin sensitivity were not observed at the timepoint when metformin‐induced changes in skeletal muscle mitochondrial capacity were detected in patients with OSA and obesity. The gene discussed is INS; the disease is obesity disorder.